Background: Recent scientific data demonstrated a potential beneficial effect of beta-blocker (BB) therapy in cardiac patients with chronic obstructive pulmonary disease (COPD). Our aim was to characterize the use of beta-blockers in these patients, in “real-life” conditions
The combination of heart failure and chronic obstructive pulmonary disease presents many therapeutic...
The combination of heart failure and chronic obstructive pulmonary disease presents many therapeutic...
Objective To examine the effect of beta blockers in the management of chronic obstructive pulmonary ...
Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) often coexist and prese...
Patients with chronic obstructive pulmonary disease (COPD) have high rates of cardiovascular comorbi...
Coronary atherosclerosis and chronic obstructive pulmonary disease (COPD) are highly prevalent, and...
Chronic obstructive pulmonary disease (COPD) is characterized by poorly reversible airflow limitatio...
Chronic obstructive pulmonary disease (COPD) is characterized by poorly reversible airflow limitatio...
The combination of heart failure and chronic obstructive pulmonary disease presents many therapeutic...
BackgroundBeta-blockers are commonly prescribed for patients with cardiovascular disease. Providers ...
The administration of beta-blockers is challenging and their efficacy is unclear in heart failure (H...
Background: Beta-blockers are commonly prescribed for patients with cardiovascular ...
The combination of heart failure and chronic obstructive pulmonary disease presents many therapeutic...
The combination of heart failure and chronic obstructive pulmonary disease presents many therapeutic...
The combination of heart failure and chronic obstructive pulmonary disease presents many therapeutic...
Objective To examine the effect of beta blockers in the management of chronic obstructive pulmonary ...
Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) often coexist and prese...
Patients with chronic obstructive pulmonary disease (COPD) have high rates of cardiovascular comorbi...
Coronary atherosclerosis and chronic obstructive pulmonary disease (COPD) are highly prevalent, and...
Chronic obstructive pulmonary disease (COPD) is characterized by poorly reversible airflow limitatio...
Chronic obstructive pulmonary disease (COPD) is characterized by poorly reversible airflow limitatio...
The combination of heart failure and chronic obstructive pulmonary disease presents many therapeutic...
BackgroundBeta-blockers are commonly prescribed for patients with cardiovascular disease. Providers ...
The administration of beta-blockers is challenging and their efficacy is unclear in heart failure (H...
Background: Beta-blockers are commonly prescribed for patients with cardiovascular ...
The combination of heart failure and chronic obstructive pulmonary disease presents many therapeutic...
The combination of heart failure and chronic obstructive pulmonary disease presents many therapeutic...
The combination of heart failure and chronic obstructive pulmonary disease presents many therapeutic...
Objective To examine the effect of beta blockers in the management of chronic obstructive pulmonary ...